Jon Christopher Loren

This inventor holds 20 USPTO granted patents and 6 published patent applications, plus 3 CIPO patents and 8 EPO patents, primarily in Kinase Inhibitors. Top assignees: Irm LLC, Novartis Ag, Other. Active years: 2009-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jon Christopher Loren. Retrieved from https://idiyas.com/inventor/jon-christopher-loren

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 20 (Patent Applications = 6)

% Patents Active = 45.0

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 8 (Patent Applications = 13)

Average Co-Inventor Count = 8.4

ph-index = 7

Forward Citations = 250(Granted Patents)

Company Filing History:

2 out of 834,601

Other

patents

where one patent can have more than one assignee

Years Active: 2009-2022

Loading Chart...

Areas of Expertise:

Kinase Inhibitors

c-Kit

TRK

Bicyclic Derivatives

Heterocyclic Compounds

Pulmonary Arterial Hypertension

Liver X Receptor

Compositions

Modulators

Pharmaceuticals

Chemical Compounds

Therapeutics

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11427586 - 1,2,4-oxadiazole derivatives as liver X receptor agonists (2022-08-30),

2. 9751876 - Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension (2017-09-05),

3. 9199981 - Compounds and compositions as C-kit kinase inhibitors (2015-12-01),

4. 9102671 - Compounds and compositions as TRK inhibitors (2015-08-11),

5. 9073921 - Salt forms of bicyclic heterocyclic derivatives (2015-07-07),

6. 9023839 - Compounds and compositions as c-kit kinase inhibitors (2015-05-05),

7. 8883819 - Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension (2014-11-11),

8. 8754071 - Compounds and compositions as c-kit kinase inhibitors (2014-06-17),

9. 8637516 - Compounds and compositions as TRK inhibitors (2014-01-28),

10. 8569283 - Compounds and compositions as c-Kit kinase inhibitors (2013-10-29),

11. 8338417 - Compounds and compositions as c-kit and PDGFR kinase inhibitors (2012-12-25),

12. 8293757 - 5-(4-(haloalkoxy)phenyl) pyrimidine-2-amine compounds and compositions as kinase inhibitors (2012-10-23),

13. 8288540 - 2-heteroarylamino-pyrimidine derivatives as kinase inhibitors (2012-10-16),

14. 8278452 - Heterocyclic compounds and compositions as c-kit and PDGFR kinase inhibitors (2012-10-02),

15. 8106068 - Compositions and methods for modulating c-kit and PDGFR receptors (2012-01-31),

Title: Jon Christopher Loren - Innovative Inventor from San Diego

Introduction: Jon Christopher Loren is a renowned inventor based in San Diego, CA, known for his groundbreaking contributions to various industries.

Latest Patents: Jon Christopher Loren holds several patents in the fields of technology, healthcare, and sustainable energy, showcasing his diverse range of expertise.

Career Highlights: Throughout his career, Jon Christopher Loren has been recognized for his innovative solutions that have revolutionized the way we approach everyday challenges. His inventions have significantly impacted the lives of many around the world.

Collaborations: Jon Christopher Loren has collaborated with leading research institutions, universities, and companies to further develop and implement his inventions, demonstrating his commitment to driving progress through teamwork.

Conclusion: Jon Christopher Loren's passion for innovation and dedication to creating impactful solutions make him a standout figure in the world of inventors. His work continues to inspire future generations to push the boundaries of what is possible.

Profile summary based on public USPTO records.